Clinical trial
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating…
NCT00004884 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00004884 |
|---|---|
| Title | Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer |
| Official title | Randomized Phase II Study of Docetaxel/Gemcitabine vs. Docetaxel/Cisplatin in Metastatic or Locoregionally Advanced Pancreatic Carcinoma |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, docetaxel, gemcitabine hydrochloride |
| Enrollment | 96 |
| Start date | Jul 1, 1999 |
| Primary completion | Mar 1, 2001 |
| First posted | May 3, 2004 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, Egypt, France, Germany, Netherlands, Poland, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: